GSK has announced that Goldman Sachs International holds a minimal percentage of its stock, refuting recent media reports of a significant stake. The company also clarified that there are no plans for asset injection or market value enhancement, cautioning investors against over-interpretation and potential investment risks. AI
RANK_REASON Company clarification regarding media reports and investor risk.
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
